Cephalon shareholders approve acquisition by Teva
14 July 2011 | By Cephalon Inc.
Cephalon, Inc. announced that its stockholders voted to approve the TEVA proposal to acquire Cephalon...
List view / Grid view
News
Novo Nordisk gains EU approval for FlexTouch®
14 July 2011 | By Novo Nordisk
Novo Nordisk has been granted approval by the European Commission for the new prefilled insulin pen – FlexTouch®...
YERVOY™ (ipilimumab) approved for the treatment of previously-treated advanced melanoma in the EU
14 July 2011 | By Bristol-Myers Squibb
The European Commission has approved YERVOY™ (ipilimumab)...
Gilead expands access program for medications in developing world
12 July 2011 | By Gilead Sciences
Gilead Sciences, Inc. announced an expansion of its global access program...
Sanofi and Regeneron report positive Phase 2b trial results with sarilumab in rheumatoid arthritis
12 July 2011 | By Sanofi
Sanofi and Regeneron Pharmaceuticals, Inc. announced results from Phase 2b trials...
Clavis Pharma appoints Nicholas Adams as Chief Business Officer
11 July 2011 | By Citigate Dewe Rogerson
Clavis Pharma ASA, is pleased to announce the appointment of Nicholas Adams as Chief Business Officer...
Lilly CEO says biopharmaceuticals should be included in transatlantic trade and economic discussions
11 July 2011 | By Eli Lilly and Company
Biopharmaceuticals be included in transatlantic trade and economic discussions...
Sanofi reports positive top-line results from first Phase 3 Study of Alemtuzumab (Lemtrada™)
11 July 2011 | By Sanofi
Sanofi and Genzyme announced positive top-line results...
Sanofi Divests Dermik Dermatology Unit to Valeant
11 July 2011 | By Sanofi
Sanofi announced the strategic divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International Inc...
Phase III trial of Novartis drug Afinitor® met primary endpoint of reducing SEGA tumor size in patients with tuberous sclerosis
8 July 2011 | By Novartis
Novartis announced Phase III trial results...
Sanofi provides Multaq® Phase IIIb PALLAS trial update
7 July 2011 | By Sanofi
Sanofi announced that the company has discontinued the PALLAS Phase IIIb trial...
Pharminox completes £1.5m funding round to progress development of novel anti-cancer drug candidates
7 July 2011 | By Citigate Dewe Rogerson
Pharminox has completed a new round of equity funding, raising approximately £1.5m...
Sage-N Research signs agreement with the U.S. Army ECBC
7 July 2011 | By The Scott Partnership
Sage-N, entered into an exclusive license agreement with the U.S. Army ECBC to commercialize a revolutionary new platform...
Novozymes Biopharma to present latest advances in drug delivery technology at Controlled Release Society Meeting
6 July 2011 | By The Scott Partnership
Two new scientific posters to be presented at the 2011 CRS meeting...
Boehringer Ingelheim and Ashoka’s Changemakers launch “Making More Health” competition
6 July 2011 | By Boehringer Ingelheim
The www.changemakers.com/morehealth competition launched...
